Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the SCD ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Novartis has said it is “disappointed” that the EMA’s Human Medicines Committee has recommended revoking the conditional EU approval for sickle cell disease (SCD) therapy Adakveo, and that it can no ...
Hypertrophic cardiomyopathy (HCM) is the most common hereditary cardiac condition and the leading cause of sudden cardiac death (SCD) in young adults. Given that SCD can be the first and most ...
Apr. 21, 2026 Tiny dinosaur fossils that puzzled scientists for over 20 years have finally revealed their true identity. Rather than belonging to a miniature species, they are actually baby ...
LMP Capital & Income Fund (SCD) quant rating optimized for predictive value. Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results